Transmembrane TNF induces an efficient cell-mediated immunity and resistance to Mycobacterium bovis bacillus Calmette-Guérin infection in the absence of secreted TNF and lymphotoxin-α

Journal of Immunology

Volumn 168, Issue 7, 2002, Pages 3394-3401

  Olleros, Maria L ^a   Guler, Reto ^a   Corazza, Nadia ^a   Vesin, Dominique ^a   Eugster, Hans Pietro ^a   Marchal, Gilles ^a   Chavarot, Pierre ^a   Mueller, Christoph ^a   Garcia, Irene ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; LYMPHOTOXIN; MEMBRANE PROTEIN; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; CELL INTERACTION; CELLULAR IMMUNITY; COLONY FORMING UNIT; CONTROLLED STUDY; ENZYME ACTIVATION; LUNG; MACROPHAGE ACTIVATION; MOUSE; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; SURVIVAL RATE; TRANSGENIC MOUSE; TUMOR VOLUME;

EID: 0036533564     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.7.3394     Document Type: Article

References (56)

1. Variation in protection by BCG: Implications of and for heterologous immunity
2. Immunological conditions of children with BCG disseminated infection
3. Interferon-γ-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection
4. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency
5. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients
6. Multiple defects of immune cell function in mice with disrupted interferon-γ genes
7. Disseminated tuberculosis in interferon γ gene-disrupted mice
8. An essential role for interferon γ in resistance to Mycobacterium tuberculosis infection
9. Mice that lack the interferon-γ receptor have profoundly altered responses to infection with bacillus Calmette-Guérin and subsequent challenge with lipopolysaccharide
10. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages
11. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis
12. Lack of both types 1 and 2 cytokines, tissue inflammatory responses, and immune protection during pulmonary infection by Mycobacterium bovis bacille Calmette-Guérin in IL-12-deficient mice
13. Immune mechanisms of protection
14. + T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon γ and nitric oxide synthase 2
15. Interferon-γ treated murine macrophages inhibit growth of tubercle bacilli via generation of reactive nitrogen intermediates
16. BCG-induced granuloma formation in murine tissue
17. Identification of nitric oxide synthase as a protective locus against tuberculosis
18. Lethal Mycobacterium bovis bacillus Calmette-Guérin infection in nitric oxide synthase 2-deficient mice: Cell-mediated immunity requires nitric oxide synthase 2
19. Improved clearance of Mycobacterium avium upon disruption of the inducible nitric oxide synthase gene
20. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection
21. Corynebacterium parvum- and Mycobacterium bovis bacillus Calmette-Guérin-induced granuloma formation is inhibited in TNF receptor I (TNF-RI) knockout mice and by treatment with soluble TNF-RI
22. Exacerbation of acute and chronic murine tuberculosis by administration of tumor necrosis factor receptor-expressing adenovirus
23. High sensitivity of transgenic mice expressing soluble TNFRI fusion protein to mycobacterial infections: Synergistic action of TNF and IFN-γ in the differentiation of protective granulomas
24. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin
25. Differential effects of TNF and LTα in the host defense against M. bovis BCG
26. Secreted lymphotoxin-α is essential for the control of an intracellular bacterial infection
27. A role for lymphotoxin β receptor in host defense against Mycobacterium bovis BCG infection
28. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
29. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α
30. Alternative cleavage of the cachectin/tumor necrosis factor propeptide results in a larger, inactive form of secreted protein
31. Generation and biological characterization of membrane-bound, uncleavable murine tumor necrosis factor
32. A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact
33. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor
34. Continuous autotropic signaling by membrane-expressed tumor necrosis factor
35. Immune and inflammatory responses in TNF α-deficient mice: A critical requirement for TNF α in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response
36. A murine transmembrane tumor necrosis factor (TNF) transgene induces arthritis by cooperative p55/p75 TNF receptor signaling
37. In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis
38. Protection against a lethal dose of endotoxin by an inhibitor of turnout necrosis factor processing
39. Noncleavable transmembrane mouse tumor necrosis factor-α (TNFα) mediates effects distinct from those of wild-type TNFα in vitro and in vivo
40. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: Implications for joint and gut-associated immunopathologies
41. Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-α double-deficient mice
42. Characterization of tumor necrosis factor-deficient mice
43. Affinity maturation without germinal centres in lymphotoxin-α-deficient mice
44. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum
45. Role of tumor necrosis factor-α in Mycobacterium-induced granuloma formation in tumor necrosis factor-α-deficient mice
46. Comparison of the roles of reactive oxygen and nitrogen intermediates in the host response to Mycobacterium tuberculosis using transgenic mice
47. + T cell clones provides a costimulatory signal for human B cell activation
48. + T lymphocyte plasma membrane
49. Comparison of γ interferon, tumor necrosis factor, and direct cell contact in activation of antimycobacterial defense in murine macrophages
50. Membrane tumour necrosis factor-α is involved in the polyclonal B-cell activation induced by HIV-infected human T cells
51. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice
52. Phosphorylation of the 26 kDa TNF precursor in monocytic cells and in transfected HeLa cells
53. A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in "reverse signaling"
54. Reverse signaling through transmembrane TNF confers resistance to lipopolysaccharide in human monocytes and macrophages
55. Tumor necrosis factor a is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system
56. The effect of a metalloproteinase inhibitor (GI5402) on tumor necrosis factor-α (TNF-α) and TNF-α receptors during human endotoxemia